Payment overview · 2025
General Payments
$258.46
13 reported records · 5 companies
Healthcare provider profile · identity verified
John D Corey, MD
Allopathic & Osteopathic Physicians|Family Medicine · PITTSBORO, NC · NPI 1578668810
Verified facts
What the public records show
CMS Open Payments records show John D Corey, MD received $258.46 in general payments during 2025 across 13 reported records.
Lilly USA, LLC accounted for 38.5% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 9 associated products.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported JARDIANCE as an associated drug or biological on 47708 records involving 23833 distinct recipient NPIs. Public Medicare Part D data also shows 46 claims for Jardiance by this doctor in 2024.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported TRULICITY as an associated drug or biological on 71 records involving 57 distinct recipient NPIs. Public Medicare Part D data also shows 26 claims for Trulicity by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Lilly USA, LLC | Unresolved — no canonical attribution shown | $99.40 | 38.5% | 5 | 2025 |
| Novo Nordisk Inc | Unresolved — no canonical attribution shown | $72.57 | 28.1% | 4 | 2025 |
| Abbott Laboratories | Unresolved — no canonical attribution shown | $38.72 | 15.0% | 2 | 2025 |
| Exact Sciences Corporation | Unresolved — no canonical attribution shown | $28.10 | 10.9% | 1 | 2025 |
| Amgen Inc. | Unresolved — no canonical attribution shown | $19.67 | 7.6% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $258.46 | 13 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| ZEPBOUND Normalized: zepbound |
Drug | Lilly USA, LLC | $99.40 | 5 | 2025 |
Source payment records
|
|||||
| MOUNJARO Normalized: mounjaro |
Drug | Lilly USA, LLC | $64.17 | 3 | 2025 |
Source payment records
|
|||||
| FREESTYLE LIBRE 3 Normalized: freestyle libre 3 |
Device | Abbott Laboratories | $38.72 | 2 | 2025 |
Source payment records
|
|||||
| Ozempic Normalized: ozempic |
Drug | Novo Nordisk Inc | $36.78 | 2 | 2025 |
Source payment records
|
|||||
| Wegovy Normalized: wegovy |
Drug | Novo Nordisk Inc | $35.79 | 2 | 2025 |
Source payment records
|
|||||
| Cologuard Collection Kit Normalized: cologuard collection kit |
Device | Exact Sciences Corporation | $28.10 | 1 | 2025 |
Source payment records
|
|||||
| OTEZLA Normalized: otezla |
Drug | Amgen Inc. | $19.67 | 1 | 2025 |
Source payment records
|
|||||
| REPATHA Normalized: repatha |
Biological | Amgen Inc. | $19.67 | 1 | 2025 |
Source payment records
|
|||||
| Rybelsus Normalized: rybelsus |
Drug | Novo Nordisk Inc | $15.66 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | JARDIANCE open payments reported associated product |
CMS Open Payments — General Payments 47708 supporting records · 23833 recipient NPIs · example record 1186464557 |
Jardiance · 2024 Exact normalized brand match · 1 Part D row |
46 | 11 |
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | TRULICITY open payments reported associated product |
CMS Open Payments — General Payments 71 supporting records · 57 recipient NPIs · example record 1186464601 |
Trulicity · 2024 Exact normalized brand match · 1 Part D row |
26 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 594 | 155 |
| Levothyroxine Sodium | Levothyroxine Sodium | 367 | 77 |
| Amlodipine Besylate | Amlodipine Besylate | 365 | 95 |
| Gabapentin | Gabapentin | 316 | 90 |
| Omeprazole | Omeprazole | 266 | 72 |
| Tamsulosin Hcl | Tamsulosin Hcl | 252 | 67 |
| Lisinopril | Lisinopril | 242 | 75 |
| Metoprolol Succinate | Metoprolol Succinate | 232 | 68 |
| Losartan Potassium | Losartan Potassium | 221 | 62 |
| Eliquis | Apixaban | 216 | 41 |
| Furosemide | Furosemide | 203 | 61 |
| Tramadol Hcl | Tramadol Hcl | 195 | 45 |
| Metformin Hcl | Metformin Hcl | 183 | 53 |
| Trazodone Hcl | Trazodone Hcl | 181 | 56 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 170 | 30 |
| Sertraline Hcl | Sertraline Hcl | 152 | 41 |
| Oxycodone Hcl | Oxycodone Hcl | 146 | 36 |
| Warfarin Sodium | Warfarin Sodium | 124 | 13 |
| Glimepiride | Glimepiride | 122 | 34 |
| Hydrochlorothiazide | Hydrochlorothiazide | 120 | 36 |
| Fluticasone Propionate | Fluticasone Propionate | 119 | 33 |
| Levetiracetam | Levetiracetam | 119 | 16 |
| Famotidine | Famotidine | 115 | 31 |
| Allopurinol | Allopurinol | 110 | 30 |
| Metoprolol Tartrate | Metoprolol Tartrate | 105 | 31 |
| Simvastatin | Simvastatin | 103 | 28 |
| Clopidogrel | Clopidogrel Bisulfate | 101 | 29 |
| Carvedilol | Carvedilol | 100 | 25 |
| Lorazepam | Lorazepam | 99 | 29 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 98 | 37 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 97 | 29 |
| Finasteride | Finasteride | 94 | 27 |
| Pantoprazole Sodium | Pantoprazole Sodium | 94 | 29 |
| Escitalopram Oxalate | Escitalopram Oxalate | 90 | 31 |
| Mirtazapine | Mirtazapine | 81 | 18 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 81 | 28 |
| Memantine Hcl | Memantine Hcl | 79 | 15 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 77 | 18 |
| Clonazepam | Clonazepam | 75 | 20 |
| Prednisone | Prednisone | 75 | 42 |
| Ibuprofen | Ibuprofen | 73 | 16 |
| Potassium Chloride | Potassium Chloride | 71 | 24 |
| Ondansetron Hcl | Ondansetron Hcl | 70 | 33 |
| Donepezil Hcl | Donepezil Hcl | 65 | 13 |
| Duloxetine Hcl | Duloxetine Hcl | 64 | 14 |
| Pravastatin Sodium | Pravastatin Sodium | 64 | 21 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 64 | 15 |
| Xarelto | Rivaroxaban | 64 | 12 |
| Diazepam | Diazepam | 63 | 12 |
| Metoclopramide Hcl | Metoclopramide Hcl | 60 | suppressed |
| Baclofen | Baclofen | 57 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 57 | 20 |
| Fluoxetine Hcl | Fluoxetine Hcl | 54 | 18 |
| Meloxicam | Meloxicam | 53 | 18 |
| Fluconazole | Fluconazole | 52 | 14 |
| Latanoprost | Latanoprost | 52 | 19 |
| Metformin Hcl Er | Metformin Hcl | 51 | 13 |
| Spironolactone | Spironolactone | 51 | 16 |
| Topiramate | Topiramate | 51 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 50 | suppressed |
| Alprazolam | Alprazolam | 49 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 48 | 28 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 47 | 11 |
| Diclofenac Sodium | Diclofenac Sodium | 46 | 18 |
| Jardiance | Empagliflozin | 46 | 11 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 45 | 16 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 45 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 45 | suppressed |
| Atenolol | Atenolol | 43 | 13 |
| Ezetimibe | Ezetimibe | 42 | 16 |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 40 | 17 |
| Methylphenidate Hcl | Methylphenidate Hcl | 40 | suppressed |
| Myrbetriq | Mirabegron | 39 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 38 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 36 | suppressed |
| Lamotrigine | Lamotrigine | 35 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 35 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 34 | 21 |
| Valacyclovir | Valacyclovir Hcl | 34 | 12 |
| Buspirone Hcl | Buspirone Hcl | 33 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 33 | 22 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 32 | 26 |
| Celecoxib | Celecoxib | 32 | 12 |
| Klor-Con 10 | Potassium Chloride | 32 | suppressed |
| Torsemide | Torsemide | 32 | suppressed |
| Colchicine | Colchicine | 31 | 12 |
| Tizanidine Hcl | Tizanidine Hcl | 31 | 11 |
| Alendronate Sodium | Alendronate Sodium | 30 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 30 | suppressed |
| Bupropion Xl | Bupropion Hcl | 30 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 30 | suppressed |
| Ketoconazole | Ketoconazole | 29 | suppressed |
| Olanzapine | Olanzapine | 29 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 29 | suppressed |
| Azithromycin | Azithromycin | 28 | 20 |
| Chlorpromazine Hcl | Chlorpromazine Hcl | 28 | suppressed |
| Estradiol | Estradiol | 28 | 12 |
| Scopolamine | Scopolamine | 28 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 27 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 27 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 26 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 26 | suppressed |
| Trulicity | Dulaglutide | 26 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 24 | 11 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 23 | suppressed |
| Glipizide Er | Glipizide | 23 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 23 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 23 | suppressed |
| Acyclovir | Acyclovir | 22 | suppressed |
| Aripiprazole | Aripiprazole | 22 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 22 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 21 | suppressed |
| Glipizide | Glipizide | 21 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 21 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 20 | suppressed |
| Carbamazepine | Carbamazepine | 20 | suppressed |
| Cephalexin | Cephalexin | 20 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 20 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 20 | suppressed |
| Lovastatin | Lovastatin | 20 | suppressed |
| Phenobarbital | Phenobarbital | 20 | suppressed |
| Prempro | Estrogen,con/M-Progest Acet | 20 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 20 | suppressed |
| Levofloxacin | Levofloxacin | 19 | 14 |
| Oxybutynin Chloride | Oxybutynin Chloride | 19 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 19 | suppressed |
| Synthroid | Levothyroxine Sodium | 19 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 18 | suppressed |
| Fenofibric Acid | Fenofibric Acid (Choline) | 18 | suppressed |
| Pregabalin | Pregabalin | 18 | suppressed |
| Terbinafine Hcl | Terbinafine Hcl | 18 | suppressed |
| Ammonium Lactate | Ammonium Lactate | 17 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 17 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 17 | 16 |
| Risperidone | Risperidone | 17 | suppressed |
| Sucralfate | Sucralfate | 17 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 16 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 16 | suppressed |
| Valsartan | Valsartan | 16 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 16 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 15 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 15 | suppressed |
| Methocarbamol | Methocarbamol | 15 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 15 | 11 |
| Advair Hfa | Fluticasone Propion/Salmeterol | 14 | suppressed |
| Cilostazol | Cilostazol | 14 | suppressed |
| Hydromorphone Hcl | Hydromorphone Hcl | 14 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 14 | suppressed |
| Ondansetron Odt | Ondansetron | 14 | 12 |
| Sumatriptan Succinate | Sumatriptan Succinate | 14 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 13 | suppressed |
| Fentanyl | Fentanyl | 13 | suppressed |
| Fluocinonide | Fluocinonide | 13 | suppressed |
| Hydrocortisone | Hydrocortisone | 13 | suppressed |
| Lidocaine | Lidocaine | 13 | suppressed |
| Methadone Hcl | Methadone Hcl | 13 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 13 | suppressed |
| Oxycontin | Oxycodone Hcl | 13 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 13 | 13 |
| Prednisolone Acetate | Prednisolone Acetate | 13 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 13 | suppressed |
| Rizatriptan | Rizatriptan Benzoate | 13 | suppressed |
| Amoxicillin | Amoxicillin | 12 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 12 | suppressed |
| Entacapone | Entacapone | 12 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 12 | suppressed |
| Lidocaine Hcl | Lidocaine Hcl | 12 | suppressed |
| Mupirocin | Mupirocin | 12 | suppressed |
| Quviviq | Daridorexant Hcl | 12 | suppressed |
| Ramipril | Ramipril | 12 | suppressed |
| Verapamil Er | Verapamil Hcl | 12 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 11 | suppressed |
| Linzess | Linaclotide | 11 | suppressed |
| Namzaric | Memantine Hcl/Donepezil Hcl | 11 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 11 | suppressed |
| Potassium Citrate Er | Potassium Citrate | 11 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 11 | 11 |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $258.46 · 13 records | Lilly USA, LLC | Cologuard Collection Kit, FREESTYLE LIBRE 3, MOUNJARO, OTEZLA, Ozempic, REPATHA, Rybelsus, Wegovy, ZEPBOUND | 2 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- How do you evaluate evidence when you have a financial relationship with Lilly USA, LLC?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error